Large-scale testing (Phase 3)Study completedNCT01346592
What this trial is testing
Safety, Tolerability, and Immunogenicity of the Adjuvanted Trivalent Subunit Influenza Vaccine and the Non-Adjuvanted Trivalent Subunit Influenza Vaccine Compared to the Non-Adjuvanted Trivalent Split Influenza Vaccine in Children 6 to < 72 Months of Age
Who this might be right for
Influenza Disease
Novartis Vaccines 6,104